A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY(2023)
摘要
This study identified new and unexpected signals of adverse drug reactions (ADRs) related to topotecan, providing valuable insights into the relationship between ADRs and topotecan usage. The findings highlight the importance of ongoing monitoring and surveillance to detect and manage AEs effectively, ultimately improving patient safety during topotecan treatment.
更多查看译文
关键词
Topotecan, BCPNN, PRR, ROR, EBGM
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要